This project will conduct the first-ever outpatient RCT to test the efficacy, safety and cost-effectiveness of the pharmaceutical cannabinoid nabiximols (Sativex®) for treating cannabis dependence.
Treatment and Intervention
This innovative, integrated care project was implemented in the South Eastern Sydney Local Health District to improve integration of services provided to those who are frequent attenders to the Emergency Department and have drug and alcohol use disorders.
This project undertakes research to understand the pathways of vulnerable adolescents and the role of the Ted Noffs Program for Adolescent Life Management (PALM) in assisting young people to get their lives back on track.
Tobacco smoking is a leading cause of preventable disease and death. Smoking rates are higher among disadvantaged Australians and facilitating smoking cessation in this group is a national health priority.
Overdose is a common event in the lives of opioid users, and is the leading cause of death in this population. Overdose risk is particularly elevated during the 4 weeks following release from prison.
This study aimed to examine the feasibility of agonist maintenance treatment for the major psychoactive drug classes: opioids, nicotine, benzodiazepines, cannabis, psychostimulants and alcohol.
The rapidity of overdose and death is of major clinical importance. Essentially, is there time to intervene, or are such deaths typically so rapid as to preclude meaningful intervention? The presence of 6-monoacetly-morphine (6MAM) is indicative of a rapid death following heroin administration.
Cannabis use disorder is the most common illegal substance use disorder in the general population and demand for assistance from health services is increasing internationally. Despite that, only a minority of those with the disorder will seek professional assistance.
The majority of calls to the Cannabis Information Helpline and indeed all counselling interventions in specialist treatment services are only one session.